194 related articles for article (PubMed ID: 19190416)
1. Improved purification process for cholera toxin and its application to the quantification of residual toxin in cholera vaccines.
Jang H; Kim HS; Kim JA; Seo JH; Carbis R
J Microbiol Biotechnol; 2009 Jan; 19(1):108-12. PubMed ID: 19190416
[TBL] [Abstract][Full Text] [Related]
2. Neutralisation of the new cholera toxin by antiserum against crude enterotoxin of cholera toxin gene-positive Vibrio cholerae 01 in rabbit ileal loop model.
Saha S; Sanyal SC
Indian J Med Res; 1989 May; 89():117-20. PubMed ID: 2777342
[TBL] [Abstract][Full Text] [Related]
3. [An avirulent vibrio cholerae strain--producer of the cholera toxin B subunit: obtaining and molecular genetic analysis].
Smirnova NI; Krepostnova IM; Livanova LF; Zadnova SP; Eremin SA; Il'ina TS
Mol Gen Mikrobiol Virusol; 2007; (4):7-13. PubMed ID: 18154075
[TBL] [Abstract][Full Text] [Related]
4. GM(1)-functionalized liposomes in a microtiter plate assay for cholera toxin in Vibrio cholerae culture samples.
Edwards KA; March JC
Anal Biochem; 2007 Sep; 368(1):39-48. PubMed ID: 17603995
[TBL] [Abstract][Full Text] [Related]
5. Formulation in tablets of a cholera whole cells inactivated vaccine candidate.
Talavera A; Año G; Pino Y; Castaño J; Uribarri E; Riverón L; Gil S; Fernández S; Cedré B; Valmaseda T; Pérez JL; Infante JF; García L; Sierra G
Vaccine; 2006 Apr; 24(16):3381-7. PubMed ID: 16460846
[TBL] [Abstract][Full Text] [Related]
6. Development and validation of a detection system for wild-type Vibrio cholerae in genetically modified cholera vaccine.
Studer E; Candrian U
Biologicals; 2000 Sep; 28(3):149-54. PubMed ID: 10964441
[TBL] [Abstract][Full Text] [Related]
7. Construction of cholera toxin B subunit-producing Vibrio cholerae strains using the Mariner-FRT transposon delivery system.
Rhie GE; Jung HM; Park J; Kim BS; Mekalanos JJ
FEMS Immunol Med Microbiol; 2008 Jan; 52(1):23-8. PubMed ID: 18070076
[TBL] [Abstract][Full Text] [Related]
8. Characterization of the binding of cholera toxin to ganglioside GM1 immobilized onto microtitre plates.
Dawson RM
J Appl Toxicol; 2005; 25(1):30-8. PubMed ID: 15669043
[TBL] [Abstract][Full Text] [Related]
9. Pathogenesis and prevention of cholera.
Holmgren J
Scand J Infect Dis Suppl; 1982; 36():58-64. PubMed ID: 6963754
[No Abstract] [Full Text] [Related]
10. Experimental immunisation and protection of guinea pigs with Vibrio cholerae toxoid and mucinases, neuraminidase and proteinase.
Stewart-Tull DE; Lucas C; Bleakley CR
Vaccine; 2004 Jun; 22(17-18):2137-45. PubMed ID: 15149770
[TBL] [Abstract][Full Text] [Related]
11. Intranasal immunization with recombinant toxin-coregulated pilus and cholera toxin B subunit protects rabbits against Vibrio cholerae O1 challenge.
Kundu J; Mazumder R; Srivastava R; Srivastava BS
FEMS Immunol Med Microbiol; 2009 Jul; 56(2):179-84. PubMed ID: 19453752
[TBL] [Abstract][Full Text] [Related]
12. Fluorescently labeled liposomes for monitoring cholera toxin binding to epithelial cells.
Edwards KA; Duan F; Baeumner AJ; March JC
Anal Biochem; 2008 Sep; 380(1):59-67. PubMed ID: 18549803
[TBL] [Abstract][Full Text] [Related]
13. Production of cholera-like enterotoxin by a Vibrio cholerae non-O1 strain isolated from the environment.
Craig JP; Yamamoto K; Takeda Y; Miwatani T
Infect Immun; 1981 Oct; 34(1):90-7. PubMed ID: 7298194
[TBL] [Abstract][Full Text] [Related]
14. Receptor-specific large-scale purification of cholera toxin on silica beads derivatized with lysoGM1 ganglioside.
Tayot JL; Holmgren J; Svennerholm L; Lindblad M; Tardy M
Eur J Biochem; 1981 Jan; 113(2):249-58. PubMed ID: 6258916
[TBL] [Abstract][Full Text] [Related]
15. Use of cholera toxoid in an enzyme-linked immunosorbent assay for antitoxin.
Cruce DD; Wachsmuth IK; Feeley JC
Diagn Immunol; 1983; 1(2):87-9. PubMed ID: 6680095
[TBL] [Abstract][Full Text] [Related]
16. Current developments with cholera vaccines: "Where do we go from here?".
Finkelstein RA
Prog Clin Biol Res; 1980; 47():133-42. PubMed ID: 7010372
[No Abstract] [Full Text] [Related]
17. A recombinant probiotic for treatment and prevention of cholera.
Focareta A; Paton JC; Morona R; Cook J; Paton AW
Gastroenterology; 2006 May; 130(6):1688-95. PubMed ID: 16697733
[TBL] [Abstract][Full Text] [Related]
18. Toxin receptors and their pathogenetic significance.
Gyr K
Acta Histochem Suppl; 1984; 29():95-102. PubMed ID: 6425929
[TBL] [Abstract][Full Text] [Related]
19. Regulation of toxin biosynthesis by plasmids in Vibrio cholerae.
Khan AA; Srivastava R; Sinha VB; Srivastava BS
J Gen Microbiol; 1985 Oct; 131(10):2653-7. PubMed ID: 3934328
[TBL] [Abstract][Full Text] [Related]
20. Process development for a Cuban cholera vaccine based on the attenuated strain Vibrio cholerae 638.
Talavera A; Año G; García H; Moreira T; Delgado H; Riverón L; Gil S; Miranda A; Cedré B; Valmaseda T; Pino Y; Pérez JL; Infante JF; García L; Sierra G
Vaccine; 2006 May; 24(18):3746-9. PubMed ID: 16085342
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
